ADR News Bulletin 2015 September (Volume 17 Number 2)
Healthcare professional
Industry member
Therapeutic Products
1 September 2015
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Bulletin Highlights:
Interim update on risk of serious ketoacidosis associated with sodium-glucose cotransporter-2 (SGLT2) inhibitors
Risk of pancreatitis associated with vemurafenib
Testosterone and risk of cardiovascular events
Partnership in vigilance: Reporting adverse events related to health products
Azithromycin and drug reaction with eosinophilia and systemic symptoms (DRESS)
Recent detection of adulterated products
List of Dear Healthcare Professional Letters
Risk of intussusception following rotavirus immunisation in Singapore
Click on the link below to download the issue in pdf:
